Following allegations of sexual harassment, former head of Operation Warp Speed Moncef Slaoui has left roles at two more companies.
Yesterday, Slaoui was terminated as the chair of the Galvani board of directors, GlaxoSmithKline’s board of directors announced. The same day, Vaxcyte confirmed in an SEC filing that it had axed Slaoui as its chairman of the board. Today, Centessa Pharmaceuticals announced that he stepped down as the company’s chief scientific officer.
Get the full story at our sister site, Drug Discovery & Development.